home / stock / nvcr / nvcr news


NVCR News and Press, NovoCure Limited From 04/03/20

Stock Information

Company Name: NovoCure Limited
Stock Symbol: NVCR
Market: NASDAQ
Website: novocure.com

Menu

NVCR NVCR Quote NVCR Short NVCR News NVCR Articles NVCR Message Board
Get NVCR Alerts

News, Short Squeeze, Breakout and More Instantly...

NVCR - Novocure Provides Business Update Related to COVID-19

Novocure to report first quarter financial results on Thursday, April 30, 2020 Novocure (NASDAQ: NVCR) today provided an update on its response to the global COVID-19 pandemic and an initial evaluation of the impact the pandemic may have on Novocure’s general business operations...

NVCR - German Federal Joint Committee Updates Medical Care Directive to include Tumor Treating Fields, establishing National Reimbursement for Optune in Germany

Directive mandates reimbursement coverage of Tumor Treating Fields for patients with newly diagnosed glioblastoma by the compulsory health insurance system Novocure (NASDAQ: NVCR) today announced that the German Federal Joint Committee, or G-BA, has updated its directive for Contracted...

NVCR - Why Novocure, Insulet, and Dexcom Are Rising Today

Shares of  Novocure (NASDAQ: NVCR) ,  Insulet (NASDAQ: PODD) , and  Dexcom   (NASDAQ: DXCM)  all rose by double digits in afternoon trading on Thursday. As of 3:15 p.m. EDT, these healthcare stocks  were up 10%, 7%, and 10%, respectively.  The major U.S. ...

NVCR - Why ShockWave Medical, Novocure, and Guardant Health Shares Tanked Today

Shares of  ShockWave Medical   (NASDAQ: SWAV) , Novocure (NASDAQ: NVCR) , and Guardant Health (NASDAQ: GH) all plunged on Monday. These healthcare stocks  ended the trading session down 15%, 12%, and 17%, respectively.  The Federal Open Market Committee, which i...

NVCR - Preclinical Data Show Tumor Treating Fields Induces Immunogenic Cell Death Resulting in Enhanced Antitumor Efficacy When Combined with Anti-PD-1 Therapy

Data from study on Tumor Treating Fields in combination with anti-PD-1 therapy published in Cancer Immunology, Immunotherapy Novocure (NASDAQ: NVCR) announced today that preclinical data on Tumor Treating Fields in combination with anti-PD-1 therapy were published in the peer-reviewe...

NVCR - NovoCure Limited (NVCR) Q4 2019 Earnings Call Transcript

Image source: The Motley Fool. NovoCure Limited   (NASDAQ: NVCR) Q4 2019 Earnings Call Feb 27, 2020 , 1:30 p.m. ET Ashley Cordova -- Senior Vice President of Finance and Investor Relations Continue reading

NVCR - Why Novocure Stock Briefly Fell Today

In response to the reported fourth-quarter and full-year results, shares of NovoCure (NASDAQ: NVCR) , a high-growth medical device company that is focused on cancer, fell as much as 12% in early-morning trading on Thursday. The stock eventually recovered and was down about 2% as of 3:0...

NVCR - NovoCure Limited (NVCR) CEO Asaf Danziger on Q4 2019 Results - Earnings Call Transcript

NovoCure Limited (NVCR) Q4 2019 Earnings Conference Call February 27, 2020 8:00 AM ET Company Participants Ashley Cordova - Senior Vice President of Finance & Investor Relations William Doyle - Executive Chairman Asaf Danziger - Chief Executive Officer Wilco Groenhuysen - C...

NVCR - Healthcare Faces A Contagion

Healthcare Pulse Source: Bloomberg The fear of Coronavirus (Covid-19) has infected the stock market. The market's patience completely ran out this week as the Coronavirus news, which has continued to weigh heavily on the negative side, sent the market reeling in a feral pullback. Wha...

NVCR - NovoCure Limited 2019 Q4 - Results - Earnings Call Presentation

The following slide deck was published by NovoCure Limited in conjunction with their 2019 Q4 earnings Read more ...

Previous 10 Next 10